Exact Sciences in advanced talks to buy Genomic Health for $2.8 billion: Bloomberg

Business

FILE PHOTO: Exact Sciences Laboratories building is shown in Madison, Wisconsin, U.S., March 28, 2019. REUTERS/Howard Schneider

(Reuters) – Cancer diagnostics company Exact Sciences Corp (EXAS.O) is in advanced negotiations to buy healthcare company Genomic Health Inc (GHDX.O) for about $2.8 billion to strengthen its cancer testing, Bloomberg reported on Saturday.

A deal could be announced as early as next week but the talks could still be delayed or fall apart altogether, according to the report, which cited people familiar with the matter.

Exact Sciences and Genomic Health did not respond immediately to a Reuters request for comment on Saturday.

Reporting by Kanishka Singh in Bengaluru; Editing by Sonya Hepinstall

Products You May Like

Articles You May Like

‘Welcome to the moon’: Spacecraft Odysseus touches down after ‘nail-biter’– first mission ever by private company
Israeli war cabinet meets amid hope new Gaza truce is close
As Dune: Part Two’s Rotten Tomatoes Score Blows Past The First Movie, Author Frank Herbert’s Son Shares Thoughts On The Adaptation
Trump wins South Carolina primary as Haley insists she is ‘not giving up fight’
Wandering Stars

Leave a Reply

Your email address will not be published. Required fields are marked *